Generic Drug Maker Defers Antitrust Prosecution, Pays $7.32M In Settlements

(June 3, 2019, 10:58 AM EDT) -- PHILADELPHIA — Generic drug maker Heritage Pharmaceuticals Inc. entered into a deferred prosecution agreement on a criminal charge of price fixing and agreed to pay a total of $7.32 million for...
To view the full article, register now.